Cleared Traditional

K034059 - SECTRA ANGIOGRAPHY PACKAGE AND SECTRA C...

K034059 is an FDA 510(k) clearance for SECTRA ANGIOGRAPHY PACKAGE AND SECTRA C..., manufactured by Sectra AB. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 69-day FDA review.

K034059 · Sectra AB · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2004
Decision
69d
Days
Class 2
Risk

K034059 is an FDA 510(k) clearance for the SECTRA ANGIOGRAPHY PACKAGE AND SECTRA CARDIOLOGY PACKAGE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Sectra AB (Denton, US). The FDA issued a Cleared decision on March 9, 2004 after a review of 69 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Sectra AB devices

FDA 510(k) Submission Details - K034059

510(k) Number K034059 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 31, 2003
Decision Date March 09, 2004
Days to Decision 69 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 107d · This submission: 69d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1204
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K034059.
MFCD 2320
K040158 · Barco N.V. · Apr 2004
CAAS II RVA
K033920 · Pie Medical Imaging BV · Mar 2004
NIO 2MP MEDICAL GRAYSCALE DISPLAY SYSTEM
K040039 · Barco N.V. · Mar 2004
3M COLOR MEDICAL FLAT PANEL DISPLAY, CCL316
K032555 · Totoku Electric Co., Ltd. · Feb 2004
VITREA2 VERSION 3.5
K040305 · Vital Images, Inc. · Feb 2004
COLOR LCD DISPLAY, MODEL RADIFORCE R22
K033466 · Eizo Nanao Corporation · Feb 2004